VRM
RMTI icon

Vectors Research Management’s Rockwell Medical RMTI Stock Holding History

Vectors Research Management’s Portfolio RMTI Stock Details RMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-113
Closed -$1K – 408
2022
Q2 		$1K Buy
+113
New +$2.99K ﹤0.01% 495
2022
Q1 		– Sell
-114
Closed -$5K – 548
2021
Q4 		$5K Hold
114
– – ﹤0.01% 511
2021
Q3 		$7K Hold
114
– – ﹤0.01% 392
2021
Q2 		$11K Buy
+114
New +$11.8K ﹤0.01% 383

Other funds holding RMTI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCA
Verdence Capital Advisors Hunt Valley, Maryland $1.72B AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vectors Research Management's RMTI Position: Q3 2022 in Review

Vectors Research Management sold out of Rockwell Medical (RMTI) in Q3 2022, closing a stake of 113 shares — an estimated $1K sold.

Vectors Research Management first reported a position in RMTI in Q2 2021 and held it in 4 quarters. The position peaked at $11K in Q2 2021. 34 funds tracked by Wall St. Rank hold RMTI as of Q3 2022.

  • Vectors Research Management reported no remaining Rockwell Medical position as of Q3 2022 after selling out during the quarter.
  • Vectors Research Management sold 113 Rockwell Medical shares in Q3 2022, an estimated $1K.
  • Vectors Research Management first reported a position in Rockwell Medical in Q2 2021 and held it in 4 quarters.
  • Vectors Research Management's Rockwell Medical position peaked at $11K in Q2 2021.
  • 34 funds tracked by Wall St. Rank held Rockwell Medical as of Q3 2022.

Based on Vectors Research Management's 13F filing for Q3 2022, filed 8 Nov 2022.